A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma
HCC stem cells were reported as posttreatment residual tumor cells that play a pivotal role in tumor relapse. Fusing dendritic cells (DCs) with tumor cells represents an ideal approach to effectively activate the antitumor immunity in vivo. DC/HCC stem cell vaccine provides a potential strategy to g...
Saved in:
| Main Authors: | Ye-Bin Pang, Jian He, Bi-Yu Cui, Sheng Xu, Xi-Lei Li, Man-Ya Wu, Rong Liang, Yan Feng, Xing Guo, Xue-Hui Zhang, Xiao-Ling Luo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2019/5680327 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Degradation of PARP1 by MARCHF3 in tumor cells triggers cCAS-STING activation in dendritic cells to regulate antitumor immunity in hepatocellular carcinoma
by: Qian Wang, et al.
Published: (2024-11-01) -
Antitumor effects of natural killer cells derived from gene-engineered human-induced pluripotent stem cells on hepatocellular carcinoma
by: Mayuna Nakamura, et al.
Published: (2025-02-01) -
Adding dendritic cell-immunotherapy for post-transplant hepatocellular carcinoma recurrence
by: Wei-Chen Lee, et al.
Published: (2025-08-01) -
Harnessing Dendritic Cell Function in Hepatocellular Carcinoma: Advances in Immunotherapy and Therapeutic Strategies
by: Shiding Ying, et al.
Published: (2025-05-01) -
Fusions of Tumor-derived Endothelial Cells with Dendritic Cells Induces Antitumor Immunity
by: Yingying Huang, et al.
Published: (2017-04-01)